Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
08/04/1994 | CA2132632A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
08/03/1994 | EP0608546A2 Glia activating factor (GAF), antibodies against it and their uses |
08/03/1994 | EP0608334A1 Sperm surface protein |
08/03/1994 | EP0608261A1 Immunoreactive hepatitis c virus polypeptide compositions |
08/03/1994 | EP0608212A1 Method of treating viral infection |
08/03/1994 | EP0220234B1 EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV |
08/03/1994 | CN1090326A Mammalian receptors for interleukin-10 (IL-10) |
08/03/1994 | CN1090324A Preparation of surface antigen of recombinant of B hepatitis |
08/03/1994 | CN1090286A Chelans possessing ortho ligating functionality and complexes thereof |
08/03/1994 | CN1090204A Novel uses of IL-4 and/or IL-10 and antibodies against the same |
08/03/1994 | CN1090203A Polypeptide vaccine for aftosa and its preparation |
08/03/1994 | CN1090202A Preparation method and application of veterinary microorganism medicine |
08/03/1994 | CA2114611A1 Method of reversing immunosuppression in vaccines |
08/02/1994 | US5334617 Preventing food spoilage and animal protein aging |
08/02/1994 | US5334394 A core particle with a surface coatings consisting of maltose, cellobiose, trehalose, isomaltose, nystose, maltotriose and nitrocellulose, bonding with immobilized virus cells; aids vaccines |
08/02/1994 | US5334379 Cytokine and hormone carriers for conjugate vaccines |
08/02/1994 | CA1331135C _-globulin injectable solutions |
08/02/1994 | CA1331134C Purification of pertussis toxins |
08/02/1994 | CA1331132C Method of treatment for non-specific inflammation |
07/27/1994 | EP0608004A2 Human DNA in the diagnosis of retinoblastoma |
07/27/1994 | EP0607425A1 Epstein-barr virus peptides and antibodies against these peptides |
07/27/1994 | EP0607408A1 Transvascular and intracellular delivery of lipidized proteins |
07/27/1994 | EP0607368A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
07/27/1994 | EP0607353A1 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
07/27/1994 | EP0607309A1 The regulation of systemic immune responses utilizing cytokines and antigens |
07/27/1994 | EP0607297A1 Hormone analogs with multiple ctp extensions |
07/27/1994 | EP0607247A1 Production of gpa neurotrophic factor |
07/27/1994 | EP0607222A1 Dendrimeric polychelants |
07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
07/27/1994 | EP0491713B1 Rubella e1 and c peptides |
07/27/1994 | EP0414816B1 Induction of tolerance to a foreign antigen |
07/27/1994 | EP0399001B1 T-cell epitope as carriers molecule for conjugate vaccines |
07/26/1994 | US5332676 Avipox virus promoter |
07/26/1994 | US5332658 Recombinant human rotavirus VP7 serotype 4 |
07/26/1994 | US5332583 Genetic engineering |
07/26/1994 | US5332572 Method for protection of swine against pleuropneumonia |
07/24/1994 | WO1994017098A1 Synthetic peptides and vaccines against parvovirus |
07/21/1994 | WO1994016330A1 Method for making a preconjugate |
07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
07/21/1994 | WO1994016083A1 Cloning of enterokinase and method of use |
07/21/1994 | WO1994016081A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv |
07/21/1994 | WO1994016070A1 Leukocyte derived growth factors |
07/21/1994 | WO1994016068A2 Allergenic proteins and peptides from dog dander and uses therefor |
07/21/1994 | WO1994015969A1 Recombinant anti-hiv antibody and preparation thereof |
07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
07/21/1994 | WO1994015965A1 Growth differentiation factor-3 |
07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
07/21/1994 | WO1994015644A1 Compounds for targeting |
07/21/1994 | WO1994015642A1 Methods of delivering agents to target cells |
07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
07/21/1994 | WO1994015640A1 Methods and compositions for the direct concentrated delivery of passive immunity |
07/21/1994 | WO1994015638A1 Antibodies directed against binding-associated epitopes |
07/21/1994 | WO1994015636A1 Vaccine preparations |
07/21/1994 | WO1994015635A1 Inducing cytotoxic t lymphocyte responses |
07/21/1994 | WO1994015634A1 Tat and rev oligopeptides in hiv treatment |
07/21/1994 | WO1994015632A1 Vaccine against trichophytosis in animals |
07/21/1994 | WO1994015593A1 Novel parasitic helminth proteins |
07/21/1994 | WO1994015586A1 Red blood cell surrogate |
07/21/1994 | WO1994015585A1 Human immunodeficiency virus decoy |
07/21/1994 | WO1994015581A1 Reduced and controlled surface binding of biologically active molecules |
07/21/1994 | WO1994012648A3 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
07/21/1994 | WO1994012144A3 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
07/21/1994 | DE4400659A1 Prodn. of viral membrane protein domains |
07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
07/21/1994 | CA2153661A1 Methods and compositions for the direct concentrated delivery of passive immunity |
07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
07/21/1994 | CA2153568A1 Methods of delivering agents to target cells |
07/21/1994 | CA2153409A1 Leukocyte derived growth factors |
07/21/1994 | CA2153147A1 Red blood cell surrogate |
07/21/1994 | CA2152915A1 Antibodies directed against binding-associated epitopes |
07/21/1994 | CA2152818A1 Allergenic proteins and peptides from dog dander and uses therefor |
07/21/1994 | CA2152490A1 Human immunodeficiency virus decoy |
07/21/1994 | CA2152379A1 Reduced and controlled surface binding of biologically active molecules |
07/21/1994 | CA2130170A1 Method for making a preconjugate |
07/20/1994 | EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same |
07/20/1994 | EP0606921A1 Method of isolating haemophilus influenzae protein E |
07/20/1994 | EP0606518A1 Intercellular adhesion molecules and their binding ligands |
07/20/1994 | EP0606452A1 Vector vaccines of recombinant feline herpesvirus |
07/20/1994 | EP0606437A1 Non-shedding live herpesvirus vaccine |
07/20/1994 | EP0606430A1 Chimeric anti-cea antibody |
07/20/1994 | EP0606391A1 Inhibition of vascular narrowing using anti-padgem antibodies |
07/20/1994 | EP0606317A1 Saponin-antigen conjugates and the use thereof |
07/20/1994 | EP0606217A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
07/20/1994 | EP0484406B1 Polypeptide inhibitor of viral replication |
07/20/1994 | EP0362283B1 Bovine interleukin-1 alpha |
07/20/1994 | CN1089660A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for......... |
07/20/1994 | CN1089478A Therapeutic agent and its use |
07/19/1994 | US5331109 Phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels |
07/19/1994 | US5331094 Purified active somatostatin receptor |
07/19/1994 | US5331093 Anti-focosylceramide monoclonal antibody |
07/19/1994 | US5330897 Sialic acid binding lectin of protozoan origin |
07/19/1994 | US5330895 Detection reagent and antibody specific for dopamine releasing protein |
07/19/1994 | US5330754 Membrane-associated immunogens of mycobacteria |
07/19/1994 | US5330753 Cholera vaccines |
07/19/1994 | CA1330791C Oral delivery system |
07/19/1994 | CA1330768C Monoclonal anti-human granulocyte colony stimulating factor antibody |
07/15/1994 | CA2381458A1 Process for constructing a cdna library and a novel polypeptide and dna coding the same |
07/13/1994 | EP0605797A1 Synthetic peptides, antibodies directed against them and their use |